How many insider declarations does 케이바이오랩스 have?

케이바이오랩스 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 케이바이오랩스?

The top reporting insider at 케이바이오랩스 is 케이바이오랩스, based on the count of public filings.

What is the net insider buy vs sell volume on 케이바이오랩스?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

케

케이바이오랩스: directors' dealings · South Korea · DART (FSS)

DART:company-03ad26KR·DART (FSS)Mcap 27.8Bn€

AMF ↗

Explore the full directors' dealings record of 케이바이오랩스, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Market capitalisation: €27.8bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: 케이바이오랩스. Every trade is openly available.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

1300.00 €

Income statement

Revenue87.31 Bn€

Gross profit12.66 Bn€14% margin

Net income−3.20 Bn€-3.7% margin

Balance sheet & cash

Market cap27.83 Bn€

Total debt585.8 M€

Free Cash Flow8.10 Bn€

Last declaration on 16 March 2026

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations